Drugmaker Elan (ELN) said it wants to merge with someone and has hired advisers (Citigroup Global Markets) to review their options. Elan is Ireland’s largest drugmaker.

It is reviewing options such as a “…minority investment, an alliance, or a merger or sale of the company.”

The stock has been down and critics blame weak sales and company mismanagement.

Currently trading at $8.15.